BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
Condition: Metastatic Colorectal Carcinoma Interventions: Drug: Encorafenib; Drug: Cetuximab Sponsors: Pierre Fabre Pharma GmbH; iOMEDICO AG; Pierre Fabre Pharma AG; Pierre Fabre Pharma Austria Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2020 Category: Research Source Type: clinical trials